Evaluation of GPT-5 for Esophageal Cancer Staging Using Fluorodeoxyglucose Positron Emission Tomography Maximum-Intensity Projection Images: Comparative Pilot Study | Synapse
February 25, 2026JMIR Cancer0 citationsOpen Access
Evaluation of GPT-5 for Esophageal Cancer Staging Using Fluorodeoxyglucose Positron Emission Tomography Maximum-Intensity Projection Images: Comparative Pilot Study
Conducted a comparative pilot study design to analyze results.
GPT-5 demonstrates improved accuracy for specific diagnostic tasks but falls short of physician-level performance.
The model shows promise in assisting with esophageal cancer staging, indicating potential for future clinical applications.
Abstract
Although current LLMs have not yet reached physician-level accuracy in comprehensive staging, recent models show promise in assisting with specific diagnostic tasks.